HIV Cure: Another Patient Declared Virus-Free

The scientific community has recently marked another milestone in the fight against HIV. Researchers have confirmed that another patient has achieved long-term remission from the virus following a stem cell transplant. While this procedure was primarily intended to treat the patient’s severe cancer, it has resulted in what scientists are cautiously calling a cure. This development adds to a small but growing list of individuals who have successfully eradicated HIV from their systems through specific medical interventions.

The 'Next Berlin Patient' and the Latest Breakthrough

In July 2024, researchers at the International AIDS Conference in Munich presented the case of the “Next Berlin Patient.” This 60-year-old German man has become the seventh person effectively cured of HIV. Like his predecessors, his remission was an incidental benefit of treating a different life-threatening condition.

The patient was diagnosed with acute myeloid leukemia (AML) in 2015. To treat the leukemia, doctors at Charité – Universitätsmedizin Berlin performed an allogeneic hematopoietic stem cell transplant. The medical team specifically searched for a donor with a rare genetic mutation known as CCR5-delta 32. This mutation makes cells resistant to HIV attachment.

Since stopping his antiretroviral therapy (ART) in late 2018, the patient has remained free of HIV for over five years. Extensive testing of his blood and tissue has shown no replicating virus. This duration of remission is significant because it moves the case past the realm of “long-term remission” and into the category of a probable cure.

Understanding the CCR5-delta 32 Mutation

To understand why these transplants work, you must look at how HIV attacks the body. The virus typically enters white blood cells (CD4 cells) by latching onto a receptor on the cell surface called CCR5.

  • The Lock: The CCR5 receptor acts like a door handle that HIV grabs to pull itself inside the cell.
  • The Key: The HIV virus carries the key to this door.
  • The Mutation: Individuals with the CCR5-delta 32 mutation are missing this specific section of the receptor. Essentially, the door handle is missing.

When a patient receives a bone marrow or stem cell transplant from a donor with this mutation, their old immune system is wiped out by chemotherapy and radiation. The donor’s stem cells then rebuild a new immune system. Because the new cells lack the “handle” HIV needs, the virus cannot enter the cells to replicate. Eventually, the remaining virus dies off because it has nowhere to go.

A Timeline of Success Stories

This method has a proven, albeit limited, track record. The “Next Berlin Patient” joins a small, exclusive club of individuals who have undergone similar procedures.

  • The Berlin Patient (Timothy Ray Brown): Treated in 2007, he was the first person cured of HIV. He remained virus-free until his death from recurrent leukemia in 2020.
  • The London Patient (Adam Castillejo): Declared cured in 2019, confirming that Brown’s case was not a fluke.
  • The DĂĽsseldorf Patient (Marc Franke): His case provided further data on the timeline of viral rebound, or lack thereof.
  • The City of Hope Patient (Paul Edmonds): At 68, he became the oldest person to achieve remission through this method, proving age is not necessarily a barrier.

These cases all share the common thread of treating blood cancers like leukemia or lymphoma, with the HIV cure occurring as a secondary, positive outcome.

Why Stem Cell Transplants Are Not a Universal Cure

While these headlines are exciting, experts emphasize that stem cell transplantation is not a viable strategy for the 39 million people currently living with HIV globally. The procedure is incredibly risky, expensive, and complex.

High Mortality Risk Stem cell transplants carry a mortality rate of roughly 10% to 20%. The process involves “conditioning,” where chemotherapy destroys the patient’s existing immune system. Following the transplant, there is a high risk of Graft-versus-Host Disease (GvHD), where the donor cells attack the recipient’s body. For someone with managed HIV who is healthy on daily medication, risking death through a transplant is not ethically justifiable.

Donor Scarcity Finding a donor is a logistical nightmare. A match must be found who is immunologically compatible with the patient (to prevent rejection) and carries the double CCR5-delta 32 mutation. This specific mutation is found in only about 1% of the Northern European population and is even rarer in other ethnic groups.

The "Geneva Patient" Anomaly

Interestingly, not every cured patient fits the CCR5 mold. The “Geneva Patient,” discussed recently by researchers at the University Hospitals of Geneva, received a transplant from a donor without the CCR5 mutation. Despite this, the patient remains in remission.

This suggests that other mechanisms might be at play. It is possible that the “Graft-versus-Host” effect, usually a complication, actually helped scour the HIV reservoir from the patient’s body. This case is crucial because it suggests that the rare mutation might not be strictly necessary, potentially widening the pool of available donors for cancer patients with HIV.

The Path Forward: Gene Editing

The real value of these cases lies in the roadmap they provide for scalable cures. Scientists are now using CRISPR and other gene-editing technologies to modify a patient’s own cells. The goal is to artificially edit the CCR5 gene to mimic the delta-32 mutation.

Biotech companies are currently running clinical trials where they extract a patient’s cells, edit them in a lab to remove the CCR5 receptor, and re-infuse them. If successful, this would bypass the need for a donor and eliminate the risk of Graft-versus-Host Disease. While early trials like those by Excision BioTherapeutics have faced hurdles, the “Next Berlin Patient” proves that the biological target is the right one.

Frequently Asked Questions

Is there a cure for HIV now available to the public? No. There is no pill or shot that cures HIV for the general public. These cures are incidental results of high-risk cancer treatments. For most people, daily antiretroviral therapy (ART) remains the standard care, allowing them to live normal lifespans.

How many people have been cured of HIV? There are approximately seven confirmed or highly probable cases of HIV cures following stem cell transplantation. These include patients treated in Berlin, London, DĂĽsseldorf, New York, and the City of Hope medical center.

What is the difference between remission and a cure? Doctors often use the term “long-term remission” first. This means the virus cannot be detected after stopping medication. If the virus remains undetectable for several years (typically 3 to 5 years) without returning, the medical community begins to classify it as a cure.

Can gene editing cure HIV? It is theoretically possible and is currently being tested. Researchers are trying to use tools like CRISPR to snip the HIV DNA out of infected cells or to delete the CCR5 receptor from healthy cells. These therapies are still in clinical trials and are not yet approved for general use.